Cancer-related inflammation and treatment effectiveness.
Explore this paper's citation graph
Summary
The complex interplay between local immune responses and systemic inflammation, and their influence on clinical outcomes, are examined, and potential anti-inflammatory interventions for patients with cancer are proposed.
- Type
- review
- Published
- 2014-10-01
- Cited by
- 2,021
- References
- 95
- OpenAlex
- https://openalex.org/W2014229457
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:43769904
Keywords
Inflammation, Cancer, Medicine, Immune system, Systemic inflammation
References
- Inflammation and prognosis in colorectal cancer.
- Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents.
- An emerging role for anti-inflammatory agents for chemoprevention.
- Statins as a newly recognized type of immunomodulator
- Therapeutic Cancer Vaccines: Past, Present and Future
- IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients1
- Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.
- Cancer and the tumor microenvironment: a review of an essential relationship
- STAT3 inhibitors for cancer therapy
- Modulation of Immunity by Antiangiogenic Molecules in Cancer
- Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
- Inflammation and oncogenesis: a vicious connection
- Cytokines as a key component of cancer-related inflammation.
- The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.
- Interleukin 18: friend or foe in cancer.
- An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.
- C‐reactive protein as a prognostic marker for men with androgen‐independent prostate cancer
- Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
- Neutrophil differentiation from human‐induced pluripotent stem cells
- The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer
Cited by
- The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy
- A functional module-based exploration between inflammation and cancer in esophagus
- Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma
- Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer.
- Defining the role of glucocorticoids in inflammation.
- Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer
- Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection
- The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma
- Preoperative neutrophil‐to‐lymphocyte ratio predicts malignancy and recurrence‐free survival of solid pseudopapillary tumor of the pancreas
- Prognostic significance of modified lung immune prognostic index in osteosarcoma patients
- Reduction of plasma fibulin-1 predicts poor survival in metastatic colorectal cancer
- In vitro COX-1 and COX-2 enzyme inhibitory activities of iridoids from Penstemon barbatus, Castilleja tenuiflora, Cresentia alata and Vitex mollis.
- Effect on long-term survival of psychiatric disorder, inflammation, malnutrition, and radiotherapy-related toxicity in patients with locally advanced head and neck cancer.
- MiR-21: an environmental driver of malignant melanoma?
- Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
- Curcumin, Inflammation, and Chronic Diseases: How Are They Linked?
- Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer
- Therapeutics targeting innate immune/inflammatory responses through the interleukin-6/JAK/STAT signal transduction pathway in patients with cancer.
- The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod
- Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria
Related papers
- Dermal Drivers of Injury-Induced Inflammation: Contribution of Adipocytes and Fibroblasts
- Characterization and differentiation of equine experimental local and early systemic inflammation by expression responses of inflammation-related genes in peripheral blood leukocytes
- Low-grade systemic inflammation and the development of metabolic diseases: From the molecular evidence to the clinical practice
- Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited
- Research progress of the mechanisms underlying transition of acute systemic inflammation to central inflammation